IRVINE, Calif. -- Advanced Sterilization Products
(ASP), a division of Ethicon, Inc., and a leading developer of
instrument processing technologies, today announced that Clarian
Health Partners' Methodist Hospital in Indianapolis is the first
hospital in the United States to acquire a STERRAD 200 System, a
new large-capacity, low-temperature sterilization system designed to
meet the demands of high-volume healthcare facilities.
The new STERRAD 200 System, which received Food and Drug
Administration (FDA) marketing clearance in August 2003, utilizes the same
proven hydrogen peroxide gas plasma technology developed by ASP for
the STERRAD 100S and STERRAD 50 Systems. It features a large-capacity
chamber that can quickly process 150 liters in just 75 minutes,
increasing efficiency and helping to reduce costs for healthcare
facilities. The STERRAD 200 System was installed at Methodist Hospital
Jan. 20, 2004.
"We are pleased that Methodist Hospital is the first U.S. user of
the new STERRAD 200 System," said Larry Creech, vice president of
perioperative services for Clarian Health Partners. "We are very
familiar with the STERRAD System, having used the technology since
1995. The new system will play a key role in processing our large
inventory of expensive and delicate medical devices and surgical
instruments. Last year alone, we spent almost $1 million on new
instruments. In addition, its large volume will translate into cost
savings on a per-load basis. With the new system, we expect to save
more than $100,000 annually, while increasing efficiency and enhancing
patient and employee safety."
According to JoEllen Barr, director of OR support services for
Clarian, the acquisition of the STERRAD 200 System also is a logical
move for the hospital based on the high volume of instruments
processed each day. "The unit is in the central sterile processing
area, which supports both surgical and clinical areas of the hospital,
so its large capacity is a key benefit," Barr said. "In addition, it
supports Clarian's continuing focus and national leadership on patient
and employee safety. Our goal is to eliminate the use of ethylene
oxide (EtO), which is a toxic substance and requires special venting.
The EtO process is lengthy and requires several hours of aeration to
eliminate the possibility of toxic residues on sterilized items. There
is significant expense associated with environmental monitoring of
work areas utilizing EtO to ensure the safety of sterile processing
staff. As a result, we continually evaluate what items can be moved
from EtO to the STERRAD System."
The STERRAD 200 System's cycle time is up to 12 times faster than
an EtO cycle, providing rapid instrument turnaround and increasing
utilization of heat- and moisture-sensitive devices. The large chamber
size enhances efficiency by increasing the amount of instruments
processed in a cycle, reducing the staff time needed to load and
unload the chamber.
According to Santi Corsaro, worldwide president of ASP, the
company is pleased and proud to have Methodist Hospital as the first
medical center in the United States to use the STERRAD 200 System.
"Methodist Hospital is a top-level medical center committed to
providing the highest quality patient care," Corsaro said. "Its focus
on innovation and leading-edge technology is reflected by its
acquisition of the STERRAD 200, and we are confident the system will
contribute to increased productivity and efficiency at Methodist."
The STERRAD Sterilization System, which is compatible with a wide
range of medical devices and surgical instruments, is based on a
patented process involving the generation of low-temperature gas
plasma from hydrogen peroxide. The system is safe for staff, patients,
and the environment; its by-products are ordinary oxygen and water.
The STERRAD 200 System is designed to leave no toxic residues on surgical
instruments or equipment, eliminating the need for a lengthy aeration
phase, and sterile instruments may be used immediately following the
sterilization cycle or stored for use when needed. Currently, there
are more than 6,000 units in use worldwide, and 23.3 million cycles
have been safely run to date.
Methodist Hospital, a part of Clarian Health Partners, is one of
only two regional Level 1 trauma centers in Indiana, has 775 staffed
beds, and is one of the largest teaching hospitals in the area. The
hospital specializes in numerous treatment areas, including adult
cardiovascular services provided in the new Clarian Cardiovascular
Center. Methodist physicians and staff performed the first open-heart
surgery in Indiana in 1965. The hospital also is considered a
neurosurgery center of excellence, as well as an expert in organ
transplantation, urology, neurology, orthopedics, and pediatrics.
Methodist also staffs the LifeLine helicopter ambulances and houses
the Indiana Poison Center.
Advanced Sterilization Products, a division of Ethicon, Inc., a
Johnson & Johnson company, manufactures and markets a full range of
innovative sterilization and disinfection technologies that safely and
effectively meet the needs of healthcare providers and patients alike.